Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae

被引:2
|
作者
Feng, Yan [1 ,2 ]
Fang, Qingqing [1 ,2 ,3 ]
Luo, Huan [2 ,4 ]
Li, Juan [1 ,2 ]
Yin, Xin [1 ,2 ]
Zong, Zhiyong [1 ,2 ,4 ,5 ]
机构
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China
[2] State Key Lab Biotherapy, Div Infect Dis, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Gen Practice Ward, Int Med Ctr Ward,Gen Practice Med Ctr, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Ctr Pathogen Res, Chengdu, Peoples R China
[5] West China Hosp Huaxi, Ctr Infect Dis, Guoxuexiang 37, Chengdu 610041, Peoples R China
关键词
Phage therapy; Antimicrobial resistance; Carbapenem-resistant Klebsiella pneumoniae; Safety; BACTERIOPHAGE;
D O I
10.1016/j.ijantimicag.2024.107088
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
<bold>Objectives: </bold>Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a leading pathogen causing difficult-to-treat, healthcare-associated wound infections. Phages are an alternative approach against CRKP. This study established murine wound infection models with a CRKP clinical strain of sequence type 11 and capsular type KL64, which is the dominant type in China, carrying genes encoding KPC-2 and NDM-1 carbapenemases. <bold>Methods: </bold>A cocktail was made comprising three lytic phages of different viral families against the strain. The phage cocktail restricted bacterial growth for 10 hours in vitro. The efficacy and safety of the phage cocktail in treating a murine wound CRKP infection were then evaluated. Mice were randomly assigned into four groups (16 for each) comprising a phage treatment group, infected with bacteria and 30 minutes later with phages, and three control groups administered with PBS (negative control), bacteria (infection control), or phages (phage control) on the wound. Wound tissues were processed for counting bacterial loads on days 1, 3, and 7 post-infection and examined for histopathological change on days 3 and 7. Two remaining mice in each group were monitored for wound healing until day 14. <bold>Results: </bold>Compared with the infection control group, the wound bacterial load in the phage treatment group decreased by 4.95 x 10(2) CFU/g (> 100-fold; P < 0.05) at day 7 post-treatment, and wounds healed on day 10, as opposed to day 14 in the infection control group. No adverse events associated with phages were observed. <bold>Conclusion: </bold>The phage cocktail significantly reduced the wound bacterial load and promoted wound healing with good safety.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae
    Aysert-Yildiz, Pinar
    Ozgen-Top, Ozge
    Habibi, Hamid
    Dizbay, Murat
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (06) : 471 - 476
  • [2] Factors influencing mortality in intracranial infections caused by carbapenem-resistant Klebsiella Pneumoniae
    Chengcheng Lai
    Zijun Ma
    Yonggang Luo
    Yuan Gao
    Zhuanghao Wu
    Jun Zhang
    Weiwei Xu
    Scientific Reports, 14 (1)
  • [3] In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae
    Huang, Wenzhi
    Qiao, Fu
    Zhang, Yinying
    Huang, Jing
    Deng, Yuhua
    Li, Jinwen
    Zong, Zhiyong
    CLINICAL INFECTIOUS DISEASES, 2018, 67 : S225 - S230
  • [4] Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity
    Diógenes Rodrigues
    Giulia Soska Baldissera
    Douglas Mathos
    Aline Sartori
    Alexandre P. Zavascki
    Maria Helena Rigatto
    Brazilian Journal of Microbiology, 2021, 52 : 1913 - 1919
  • [5] Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity
    Rodrigues, Diogenes
    Baldissera, Giulia Soska
    Mathos, Douglas
    Sartori, Aline
    Zavascki, Alexandre P.
    Rigatto, Maria Helena
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2021, 52 (04) : 1913 - 1919
  • [6] Safety and Efficacy of a Phage, kpssk3, in an in vivo Model of Carbapenem-Resistant Hypermucoviscous Klebsiella pneumoniae Bacteremia
    Shi, Yunlong
    Peng, Yuan
    Zhang, Yixin
    Chen, Yu
    Zhang, Cheng
    Luo, Xiaoqiang
    Chen, Yajie
    Yuan, Zhiqiang
    Chen, Jing
    Gong, Yali
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [7] Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
    Bandick, Rasmus G.
    Mousavi, Soraya
    Bereswill, Stefan
    Heimesaatp, Markus M.
    EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY, 2020, 10 (03): : 115 - 124
  • [8] Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections
    Pistella, Eleonora
    Santini, Claudio
    ITALIAN JOURNAL OF MEDICINE, 2016, 10 (04) : 339 - 348
  • [9] Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
    Neuner, Elizabeth A.
    Yeh, Jun-Yen
    Hall, Gerri S.
    Sekeres, Jennifer
    Endimiani, Andrea
    Bonomo, Robert A.
    Shrestha, Nabin K.
    Fraser, Thomas G.
    van Duin, David
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 69 (04) : 357 - 362
  • [10] Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China
    Liang, Xiaoxue
    Chen, Ping
    Deng, Baoguo
    Sun, Feng-Hui
    Yang, Yongqiang
    Yang, Yanxian
    He, Ruowen
    Qin, Mingyang
    Wu, Yiping
    Yang, Fan
    Tian, Guo-Bao
    Dai, Min
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 3161 - 3171